V.M. Andreoli

581 total citations
30 papers, 406 citations indexed

About

V.M. Andreoli is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, V.M. Andreoli has authored 30 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in V.M. Andreoli's work include Diet and metabolism studies (5 papers), Folate and B Vitamins Research (4 papers) and Epigenetics and DNA Methylation (3 papers). V.M. Andreoli is often cited by papers focused on Diet and metabolism studies (5 papers), Folate and B Vitamins Research (4 papers) and Epigenetics and DNA Methylation (3 papers). V.M. Andreoli collaborates with scholars based in Italy, United Kingdom and United States. V.M. Andreoli's co-authors include M Casacchia, A. Agnoli, R. Cerbo, Márcio Versiani, Giancarlo Tonon, Vincent Caillard, Janusz Rybakowski, C. L. Cazzullo, Giulio L. Cantoni and Leonard L. Ross and has published in prestigious journals such as The Lancet, Trends in Neurosciences and Brain Research.

In The Last Decade

V.M. Andreoli

30 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V.M. Andreoli Italy 11 97 79 77 74 56 30 406
Alvin M. Janski United States 12 251 2.6× 153 1.9× 38 0.5× 32 0.4× 95 1.7× 19 605
I. Gottfries Sweden 7 64 0.7× 93 1.2× 32 0.4× 110 1.5× 177 3.2× 10 483
Emilene Barros da Silva Scherer Brazil 14 101 1.0× 25 0.3× 122 1.6× 36 0.5× 52 0.9× 22 490
A. Tallón-Barranco Spain 14 156 1.6× 44 0.6× 52 0.7× 94 1.3× 106 1.9× 18 541
Ildiko Wichart Austria 13 143 1.5× 70 0.9× 30 0.4× 142 1.9× 118 2.1× 23 582
Related Disorders 5 135 1.4× 87 1.1× 98 1.3× 88 1.2× 58 1.0× 6 490
Paul F. Boston United Kingdom 10 281 2.9× 79 1.0× 20 0.3× 85 1.1× 34 0.6× 16 570
H.C. Stancer Canada 12 107 1.1× 33 0.4× 14 0.2× 88 1.2× 123 2.2× 24 446
Toshimasa Sakamoto United States 7 123 1.3× 27 0.3× 40 0.5× 58 0.8× 135 2.4× 13 490
Andréa G. K. Ferreira Brazil 15 117 1.2× 29 0.4× 114 1.5× 30 0.4× 70 1.3× 30 494

Countries citing papers authored by V.M. Andreoli

Since Specialization
Citations

This map shows the geographic impact of V.M. Andreoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.M. Andreoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.M. Andreoli more than expected).

Fields of papers citing papers by V.M. Andreoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V.M. Andreoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.M. Andreoli. The network helps show where V.M. Andreoli may publish in the future.

Co-authorship network of co-authors of V.M. Andreoli

This figure shows the co-authorship network connecting the top 25 collaborators of V.M. Andreoli. A scholar is included among the top collaborators of V.M. Andreoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V.M. Andreoli. V.M. Andreoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andreoli, V.M., et al.. (2002). Reboxetine, a New Noradrenaline Selective Antidepressant, Is at Least as Effective as Fluoxetine in the Treatment of Depression. Journal of Clinical Psychopharmacology. 22(4). 393–399. 44 indexed citations
2.
Andreoli, V.M., Giovanni Carbognin, Andrea Abati, & G. Vantini. (1999). Reboxetine in the Treatment of Depression in the Elderly: Pilot Study. Journal of Geriatric Psychiatry and Neurology. 12(4). 206–210. 8 indexed citations
3.
Naber, Dieter, et al.. (1999). Psyche & Kunst : psychiatrisch-kunsthistorische Anthologie : Katalog zur Ausstellung anlässlich des XI. Weltkongresses für Psychiatrie in Hamburg 1999. Medical Entomology and Zoology. 1 indexed citations
4.
Andreoli, V.M.. (1996). Biological psychiatry. Neuropsychologia. 34(12). 1247–1248. 43 indexed citations
5.
Sgaragli, G.P., Laura Corte, Massimo Valoti, et al.. (1986). Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.. Drug Metabolism and Disposition. 14(2). 263–266. 20 indexed citations
6.
Andreoli, V.M., et al.. (1978). S-Adenosyl-L-Methionine (SAMe) Blood Levels in Schizophrenia and Depression. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18. 147–150. 3 indexed citations
7.
Agnoli, A., et al.. (1978). Results and Possible Developments of the Clinical Use of S-Adenosyl-L-Methionine (SAMe) in Psychiatry. PubMed. 18. 170–182. 10 indexed citations
8.
Andreoli, V.M., et al.. (1978). Transmethylations and the Central Nervous System. 15 indexed citations
9.
Andreoli, V.M., et al.. (1978). The Subcellular Distribution of S-Adenosyl-L-Methionine (SAMe) in the Rat Brain. PubMed. 18. 114–118. 3 indexed citations
10.
Agnoli, A., V.M. Andreoli, M Casacchia, & R. Cerbo. (1976). Effect of S-Adenosyl-L-Methionine (SAMe) upon depressive symptoms. Journal of Psychiatric Research. 13(1). 43–54. 76 indexed citations
11.
Andreoli, V.M., et al.. (1975). BLOOD-LEVELS OF S-ADENOSYLMETHIONINE IN SCHIZOPHRENIA. The Lancet. 306(7941). 922–922. 19 indexed citations
12.
Canal, N., et al.. (1974). Lipid changes in neurogenic muscular atrophies. Research in Experimental Medicine. 164(3). 241–246. 3 indexed citations
13.
Andreoli, V.M., Francisco H.A. Maffei, Giancarlo Tonon, & A. Zibetti. (1973). Significance of plasma lysolecithin in patients with multiple sclerosis: a longitudinal study. Journal of Neurology Neurosurgery & Psychiatry. 36(4). 661–667. 14 indexed citations
14.
Andreoli, V.M., Francisco H.A. Maffei, Giuseppe Arienti, et al.. (1973). Increased lecithin-cholesterol acyltransferase activity in multiple sclerosis patients. Pharmacological Research Communications. 5(1). 37–40. 4 indexed citations
15.
Andreoli, V.M., Flavio Villani, & G. Brambilla. (1972). Increased calcium and magnesium excretion induced by lithium carbonate. Psychopharmacology. 25(1). 77–85. 17 indexed citations
16.
Andreoli, V.M., et al.. (1971). Platelet lipids: Effects of a high fat or a high carbohydrate diet in pig plasma and platelet fatty acid composition. Life Sciences. 10(9). 481–493. 11 indexed citations
17.
Mangoni, Arduino A., et al.. (1970). BODY FLUID DISTRIBUTION IN MANIC AND DEPRESSED PATIENTS TREATED WITH LITHIUM CARBONATE *. Acta Psychiatrica Scandinavica. 46(3). 244–257. 8 indexed citations
18.
Andreoli, V.M., et al.. (1970). Subcellular fractionation of hypothalamus and pituitary stalk of the bull. Morphologic study and serotonin-norepinephrine distribution. Experimental Brain Research. 11(1). 17–28. 3 indexed citations
19.
Andreoli, V.M.. (1968). Platelet lipids. II. In vitro incorporation of 1-14C palmitic acid into lipid fractions of rabbit platelets. European Journal of Pharmacology. 4(4). 404–410. 9 indexed citations
20.
Andreoli, V.M.. (1968). A sex difference in some toxic effects of lithium-carbonate. Cellular and Molecular Life Sciences. 24(11). 1155–1155. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026